Our company's innovation comes from its unique position at the intersection of nature and technology, where we solve the problem of translating natural discoveries into medicine. PEEL develops and acquires evolution-based drugs that use nanotechnology and other advanced delivery systems to treat and prevent disease.
Since the beginning of recorded history, humans have used the ingredients found in nature to provide cures for our ailments. The tools at our disposal today, from genetic analysis to cutting-edge nanotechnologies, have allowed PEEL scientists to continue to discover and apply nature's solutions to health and human diseases. Comparative biology, the study of one species to learn about the biological systems of another, has become a powerful tool to understand why humans develop diseases and learn about ways that other species avoid them.
At PEEL Therapeutics, rather than reinventing the "biological wheel," we apply millions of years in Research & Development that nature invested in elegant and evolutionary solutions to disease. PEEL's team of scientists and innovators pick up where nature left off and merge these solutions with advanced technology to develop new medicines for human patients. The PEEL team remains focused on achieving the milestones necessary to bring the existing assets to market, while evolution provides a continuous source of opportunities for future development.